
LifeMD LFMD
$ 3.45
-4.43%
Quarterly report 2025-Q3
added 11-17-2025
LifeMD Interest Expense 2011-2025 | LFMD
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense LifeMD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.6 M | 1.28 M | 3.02 M | 1.67 M | 761 K | 354 K | 101 K | 48.6 K | 37.5 K | 4.68 K | 3.38 K | 3.37 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.02 M | 3.37 K | 823 K |
Quarterly Interest Expense LifeMD
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 262 K | 663 K | 626 K | - | 559 K | 531 K | 478 K | - | 714 K | 996 K | 264 K | - | 132 K | 132 K | 168 K | - | 1.82 M | 902 K | 139 K | - | 291 K | 229 K | 793 K | - | 131 K | 130 K | 170 K | - | 148 K | 148 K | 6.45 K | - | 1.11 K | 250 | 649 K | - | 9.99 K | 2.75 K | 3.06 K | - | 14.4 K | 8.16 K | 10.5 K | - | 259 | 428 | 478 | - | - | - | - | - | - | 443 | 2.93 K | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.82 M | 250 | 293 K |
Interest Expense of other stocks in the Pharmaceutical retailers industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Greenlane Holdings
GNLN
|
2.45 M | $ 2.99 | -3.24 % | $ 22.5 M | ||
|
BOQI International Medical
BIMI
|
170 K | - | 6.33 % | $ 5.86 M | ||
|
Trxade Group
MEDS
|
1.2 M | - | 4.55 % | $ 5.8 M | ||
|
PetMed Express
PETS
|
758 K | $ 3.02 | 70.69 % | $ 62.2 M | ||
|
Rite Aid Corporation
RAD
|
224 M | - | - | $ 35.5 M | ||
|
111
YI
|
-595 K | $ 3.7 | -4.15 % | $ 636 M | ||
|
Walgreens Boots Alliance
WBA
|
482 M | - | - | $ 10.3 B |